Interestingly, direct siRNA silencing of XRCC5 enhanced low-dose SASP (0.1mM)-induced PEL apoptosis, potentially due to impaired DNA-damage repair machinery in tumor cells (Figures 6A and S6). The gene discussed is XRCC5; the disease is neoplasm.